{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:02:35Z","timestamp":1788984155534,"version":"build-2803163510"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/202.215\/2019"],"award-info":[{"award-number":["E-26\/202.215\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/201.431\/2022"],"award-info":[{"award-number":["E-26\/201.431\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E26\/210.108\/2022"],"award-info":[{"award-number":["E26\/210.108\/2022"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>This work investigated the acute antinociceptive effect of a synthetic chalcone, 4-dimethylamino chalcone (DMAC), as well as its effects on vincristine-induced peripheral neuropathy (VIPN) in mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The inhibitory activity of myeloperoxidase was assessed by measuring HOCl formation. Formalin and hot plate tests were used to study the acute antinociceptive effect of DMAC. VIPN was induced through the administration of vincristine sulphate (0.1 mg\/kg, i.p., 14 days). Then, DMSO, DMAC (10 or 30 mg\/kg; i.p.), or pregabalin (10 mg\/kg, i.p.) were administered for 14 consecutive days. Thermal hyperalgesia and mechanical allodynia were evaluated before and after VIPN induction and on days 1, 3, 7, and 14 of treatment. Neurodegeneration and neuroinflammation were assessed through immunohistochemistry for NF200, iNOS, and arginase-1 within the sciatic nerve.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Key findings<\/jats:title>\n                  <jats:p>DMAC inhibited myeloperoxidase activity in vitro and presented an acute antinociceptive effect in both formalin and hot plate tests, with the involvement of muscarinic and opioid receptors. Treatment with 30 mg\/kg of DMAC significantly attenuated thermal hyperalgesia and mechanical allodynia and prevented macrophage proinflammatory polarisation in VIPN mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our results show that DMAC, acting through different mechanisms, effectively attenuates VIPN.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jpp\/rgae057","type":"journal-article","created":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T17:03:22Z","timestamp":1715447002000},"page":"983-994","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacological potential of 4-dimethylamino chalcone against acute and neuropathic pain in mice"],"prefix":"10.1093","volume":"76","author":[{"given":"Isabela Souza dos Santos","family":"Marchon","sequence":"first","affiliation":[{"name":"Grupo de Pesquisa em Farmacologia de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27930-560 ,","place":["Brazil"]},{"name":"Laborat\u00f3rio de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27933-378 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelynn Dalila do Nascimento","family":"Melo","sequence":"additional","affiliation":[{"name":"Grupo de Pesquisa em Farmacologia de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27930-560 ,","place":["Brazil"]},{"name":"Laborat\u00f3rio de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27933-378 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella da Costa","family":"Botinh\u00e3o","sequence":"additional","affiliation":[{"name":"Grupo de Pesquisa em Farmacologia de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27930-560 ,","place":["Brazil"]},{"name":"Laborat\u00f3rio de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27933-378 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greice Nascimento","family":"Pires","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio Integrado de Morfologia, Universidade Federal do Rio de Janeiro, Instituto de Biodiversidade e Sustentabilidade NUPEM , Maca\u00e9, RJ 27965-045 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Vitor Rocha","family":"Reis","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27933-378 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo Octavio Mendon\u00e7a Alves","family":"de Souza","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Biocat\u00e1lise e S\u00edntese Org\u00e2nica, Instituto de Qu\u00edmica, Universidade Federal do Rio de Janeiro , Rio de Janeiro, RJ 21941-909 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6917-9323","authenticated-orcid":false,"given":"Ivana Correa Ramos","family":"Leal","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Produtos Naturais e Ensaios Biol\u00f3gicos, Faculdade de Farm\u00e1cia, Universidade Federal do Rio de Janeiro , Rio de Janeiro, RJ 21941-902 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-2478","authenticated-orcid":false,"given":"Andr\u00e9 Gustavo Calvano","family":"Bonavita","sequence":"additional","affiliation":[{"name":"Grupo de Pesquisa em Farmacologia de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27930-560 ,","place":["Brazil"]},{"name":"Laborat\u00f3rio de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27933-378 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrique Rocha","family":"Mendon\u00e7a","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio Integrado de Morfologia, Universidade Federal do Rio de Janeiro, Instituto de Biodiversidade e Sustentabilidade NUPEM , Maca\u00e9, RJ 27965-045 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle Fraz\u00e3o","family":"Muzitano","sequence":"additional","affiliation":[{"name":"Laborat\u00f3rio de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27933-378 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Louback","family":"da Silva","sequence":"additional","affiliation":[{"name":"Grupo de Pesquisa em Farmacologia de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27930-560 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula Lima","family":"do Carmo","sequence":"additional","affiliation":[{"name":"Grupo de Pesquisa em Farmacologia de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27930-560 ,","place":["Brazil"]},{"name":"Laborat\u00f3rio de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27933-378 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9152-4931","authenticated-orcid":false,"given":"Juliana Montani","family":"Raimundo","sequence":"additional","affiliation":[{"name":"Grupo de Pesquisa em Farmacologia de Produtos Bioativos, Universidade Federal do Rio de Janeiro, Centro Multidisciplinar UFRJ-Maca\u00e9 , Maca\u00e9, RJ 27930-560 ,","place":["Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,1]]},"reference":[{"key":"2024110501464625700_CIT0001","year":"2022"},{"key":"2024110501464625700_CIT0002","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1007\/s13311-021-01142-2","article-title":"Chemotherapy-induced peripheral neuropathy: mechanisms and therapeutic avenues","volume":"18","author":"Bae","year":"2021","journal-title":"Neurotherapeutics"},{"key":"2024110501464625700_CIT0003","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s40487-021-00168-y","article-title":"Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms, and treatment","volume":"9","author":"Burgess","year":"2021","journal-title":"Oncol Ther"},{"key":"2024110501464625700_CIT0004","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.pain.2014.09.020","article-title":"Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis","volume":"155","author":"Seretny","year":"2014","journal-title":"Pain"},{"key":"2024110501464625700_CIT0005","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"key":"2024110501464625700_CIT0006","first-page":"1231","article-title":"Vinca alkaloids","volume":"4","author":"Moudi","year":"2013","journal-title":"Int J Prev Med"},{"key":"2024110501464625700_CIT0007","first-page":"2416","article-title":"Vincristine-induced peripheral neuropathy in pediatric cancer patients","volume":"6","author":"Mora","year":"2016","journal-title":"Am J Cancer Res"},{"key":"2024110501464625700_CIT0008","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00280-019-03884-5","article-title":"Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review","volume":"84","author":"Madsen","year":"2019","journal-title":"Cancer Chemother Pharmacol"},{"key":"2024110501464625700_CIT0009","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/j.pain.0000000000001528","article-title":"Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy","volume":"160","author":"DiAntonio","year":"2019","journal-title":"Pain"},{"key":"2024110501464625700_CIT0010","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1007\/s11064-016-2040-8","article-title":"Neuroprotective effect of matrine in mouse model of vincristine-induced neuropathic pain","volume":"41","author":"Gong","year":"2016","journal-title":"Neurochem Res"},{"key":"2024110501464625700_CIT0011","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11418-011-0525-y","article-title":"Attenuating effect of hydroalcoholic extract of Acorus calamus in vincristine-induced painful neuropathy in rats","volume":"65","author":"Muthuraman","year":"2011","journal-title":"J Nat Med"},{"key":"2024110501464625700_CIT0012","doi-asserted-by":"crossref","first-page":"434","DOI":"10.4097\/kja.19481","article-title":"Antiallodynic and anti-inflammatory effects of intrathecal R-PIA in a rat model of vincristine-induced peripheral neuropathy","volume":"73","author":"Kim","year":"2020","journal-title":"Korean J Anesthesiol"},{"key":"2024110501464625700_CIT0013","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cyto.2012.03.027","article-title":"Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy","volume":"59","author":"Wang","year":"2012","journal-title":"Cytokine"},{"key":"2024110501464625700_CIT0014","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.pain.2013.06.022","article-title":"Glia and pain: is chronic pain a gliopathy","volume":"154","author":"Ji","year":"2013","journal-title":"Pain"},{"key":"2024110501464625700_CIT0015","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-023-00776-9","article-title":"Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship","volume":"20","author":"Lustberg","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"2024110501464625700_CIT0016","first-page":"583","article-title":"Synthesis and assessment of anti-inflammatory activity of a chlorosubstituted chalcone derivatives and using the semi-empirical methods to measure the linked physicochemical parameters","volume":"6","author":"Mousa","year":"2016","journal-title":"J Pharm Biomed Sci"},{"key":"2024110501464625700_CIT0017","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0223-5234(02)01387-9","article-title":"Synthesis and inhibitory activity of dimethylamino-chalcone derivatives on the induction of nitric oxide synthase","volume":"37","author":"Rojas","year":"2002","journal-title":"Eur J Med Chem"},{"key":"2024110501464625700_CIT0018","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/FBP.0000000000000577","article-title":"Anti-inflammatory and anti-hypersensitive effects of the chalcone isocordoin and its semisynthetic derivatives in mice","volume":"31","author":"Da Silva","year":"2020","journal-title":"Behav Pharmacol"},{"key":"2024110501464625700_CIT0019","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s00210-020-01922-1","article-title":"Effects of 2","volume":"393","author":"Cerutti","year":"2020","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"2024110501464625700_CIT0020","doi-asserted-by":"crossref","first-page":"104773","DOI":"10.1016\/j.bioorg.2021.104773","article-title":"Chalcones and their B-aryl analogues as myeloperoxidase inhibitors: in silico, in vitro and ex vivo investigations","volume":"110","author":"Santos","year":"2021","journal-title":"Bioorg Chem"},{"key":"2024110501464625700_CIT0021","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.2174\/092986712803833344","article-title":"4","volume":"19","author":"Zeraik","year":"2012","journal-title":"Curr Med Chem"},{"key":"2024110501464625700_CIT0022","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/1521-4184(200110)334:10<332::AID-ARDP332>3.0.CO;2-O","article-title":"Antinociceptive properties of chalcones. Structure","volume":"334","author":"Corr\u00eaa","year":"2001","journal-title":"Arch Pharm (Weinheim)"},{"key":"2024110501464625700_CIT0023","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2010.08.030","article-title":"Antinociceptive activity of a synthetic chalcone, flavokawin B on chemical and thermal models of nociception in mice","volume":"647","author":"Mohamed","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"2024110501464625700_CIT0024","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3390\/molecules21081077","article-title":"Antinociceptive effect of 3-(2,3-dimethoxyphenyl)-1-(5-methylfuran-2-yl) prop-2-en-1-one in mice models of induced nociception","volume":"21","author":"Ismail","year":"2016","journal-title":"Molecules"},{"key":"2024110501464625700_CIT0025","doi-asserted-by":"crossref","first-page":"173184","DOI":"10.1016\/j.ejphar.2020.173184","article-title":"Serotonergically dependent antihyperalgesic and antiallodynic effects of isoliquiritin in a mouse model of neuropathic pain","volume":"881","author":"Yu","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"2024110501464625700_CIT0026","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.3390\/molecules26123677","article-title":"Cardamonin modulates neuropathic pain through the possible involvement of serotonergic 5-HT1A receptor pathway in CCI-induced neuropathic pain mice model","volume":"26","author":"Kaswan","year":"2021","journal-title":"Molecules"},{"key":"2024110501464625700_CIT0027","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1007\/s11064-021-03244-x","article-title":"Licochalcone A attenuates chronic neuropathic pain in rats by inhibiting microglia activation and inflammation","volume":"46","author":"Li","year":"2021","journal-title":"Neurochem Res"},{"key":"2024110501464625700_CIT0028","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.3390\/molecules20058072","article-title":"Antimycobacterial and anti-inflammatory activities of substituted chalcones focusing on an anti-tuberculosis dual treatment approach","volume":"20","author":"Ventura","year":"2015","journal-title":"Molecules"},{"key":"2024110501464625700_CIT0029","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S0076-6879(94)33056-5","article-title":"Assays for the chlorination activity of myeloperoxidase","volume":"233","author":"Kettle","year":"1994","journal-title":"Methods Enzymol"},{"key":"2024110501464625700_CIT0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3959(87)90088-1","article-title":"The formalin test in mice: dissociation between inflammatory and non-inflammatory pain","volume":"30","author":"Hunskaar","year":"1987","journal-title":"Pain"},{"key":"2024110501464625700_CIT0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12906-015-0724-2","article-title":"Antinociceptive effects of hydroalcoholic extract from Euterpe oleracea Mart. (A\u00e7a\u00ed) in a rodent model of acute and neuropathic pain","volume":"15","author":"Sudo","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"2024110501464625700_CIT0032","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.nutres.2013.02.011","article-title":"Eicosapentaenoic acid and docosahexaenoic acid exert anti-inflammatory and antinociceptive effects in rodents at low doses","volume":"33","author":"Nobre","year":"2013","journal-title":"Nutr Res"},{"key":"2024110501464625700_CIT0033","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bbi.2019.09.012","article-title":"Prokineticin 2 promotes and sustains neuroinflammation in vincristine treated mice: focus on pain and emotional like behaviour","volume":"82","author":"Moschetti","year":"2019","journal-title":"Brain Behav Immun"},{"key":"2024110501464625700_CIT0034","doi-asserted-by":"crossref","first-page":"838","DOI":"10.3109\/13880209.2014.943247","article-title":"Effect of curcumin in mice model of vincristine-induced neuropathy","volume":"53","author":"Babu","year":"2015","journal-title":"Pharm Biol"},{"key":"2024110501464625700_CIT0035","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods used to evaluate pain behaviours in rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"2024110501464625700_CIT0036","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2018.07.018","article-title":"Lack of galectin-3 attenuates neuroinflammation and protects the retina and optic nerve of diabetic mice","volume":"1700","author":"Mendon\u00e7a","year":"2018","journal-title":"Brain Res"},{"key":"2024110501464625700_CIT0037","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.neuro.2020.10.004","article-title":"Vincristine-induced peripheral neuropathy: a mini-review","volume":"81","author":"Li","year":"2020","journal-title":"Neurotoxicology"},{"key":"2024110501464625700_CIT0038","doi-asserted-by":"crossref","first-page":"782275","DOI":"10.3389\/fncel.2021.782275","article-title":"Nuclear factor \u03baB-COX2 pathway activation in non-myelinating Schwann cells is necessary for the maintenance of neuropathic pain in vivo","volume":"15","author":"Xie","year":"2022","journal-title":"Front Cell Neurosci"},{"key":"2024110501464625700_CIT0039","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/ATVBAHA.113.301453","article-title":"Transcriptional control of macrophage polarisation","volume":"33","author":"Tugal","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024110501464625700_CIT0040","first-page":"597","article-title":"Animal models of nociception","volume":"53","author":"Le Bars","year":"2001","journal-title":"Pharmacol Rev"},{"key":"2024110501464625700_CIT0041","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ejps.2016.01.019","article-title":"Quercetin derivative induces cell death in glioma cells by modulating NF-\u03baB nuclear translocation and caspase-3 activation","volume":"84","author":"Kiekow","year":"2016","journal-title":"Eur J Pharm Sci"},{"key":"2024110501464625700_CIT0042","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1471-4159.2009.06396.x","article-title":"Role of M2, M3, and M4 muscarinic receptor subtypes in the spinal cholinergic control of nociception revealed using siRNA in rats","volume":"111","author":"Cai","year":"2009","journal-title":"J Neurochem"},{"key":"2024110501464625700_CIT0043","doi-asserted-by":"crossref","first-page":"40427","DOI":"10.1074\/jbc.M110.176966","article-title":"Dynamic control of glutamatergic synaptic input in the spinal cord by muscarinic receptor subtypes defined using knockout mice","volume":"285","author":"Chen","year":"2010","journal-title":"J Biol Chem"},{"key":"2024110501464625700_CIT0044","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.niox.2011.06.004","article-title":"Pain and analgesia: the dual effect of nitric oxide in the nociceptive system","volume":"25","author":"Cury","year":"2011","journal-title":"Nitric Oxide"},{"key":"2024110501464625700_CIT0045","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.bjp.0706731","article-title":"Spinal alpha(2)-adrenergic and muscarinic receptors and the NO release cascade mediate supraspinally produced effectiveness of gabapentin at decreasing mechanical hypersensitivity in mice after partial nerve injury","volume":"148","author":"Takasu","year":"2006","journal-title":"Br J Pharmacol"},{"key":"2024110501464625700_CIT0046","doi-asserted-by":"crossref","first-page":"113862","DOI":"10.1016\/j.bcp.2020.113862","article-title":"Peripheral nitric oxide signalling directly blocks inflammatory pain","volume":"176","author":"Gomes","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"2024110501464625700_CIT0047","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejphar.2016.12.020","article-title":"Cardamonin attenuates hyperalgesia and allodynia in a mouse model of chronic constriction injury-induced neuropathic pain: possible involvement of the opioid system","volume":"796","author":"Sambasevam","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"2024110501464625700_CIT0048","doi-asserted-by":"crossref","first-page":"104499","DOI":"10.1016\/j.ebiom.2023.104499","article-title":"Neutrophil extracellular traps as a unique target in the treatment of chemotherapy-induced peripheral neuropathy","volume":"90","author":"Wang","year":"2023","journal-title":"EBioMedicine"},{"key":"2024110501464625700_CIT0049","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3389\/fnins.2017.00481","article-title":"A mechanistic understanding of axon degeneration in chemotherapy-induced peripheral neuropathy","volume":"11","author":"Fukuda","year":"2017","journal-title":"Front Neurosci"},{"key":"2024110501464625700_CIT0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2008.07.008","article-title":"The critical role of invading peripheral macrophage-derived interleukin-6 in vincristine-induced mechanical allodynia in mice","volume":"592","author":"Kiguchi","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"2024110501464625700_CIT0051","doi-asserted-by":"crossref","first-page":"e20201452","DOI":"10.1084\/jem.20201452","article-title":"Vincristine-induced peripheral neuropathy is driven by canonical NLRP3 activation and IL-1\u03b2 release","volume":"218","author":"Starobova","year":"2021","journal-title":"J Exp Med"},{"key":"2024110501464625700_CIT0052","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3389\/fimmu.2014.00532","article-title":"Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages","volume":"5","author":"Rath","year":"2014","journal-title":"Front Immunol"},{"key":"2024110501464625700_CIT0053","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1172\/JCI71389","article-title":"Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain","volume":"124","author":"Old","year":"2014","journal-title":"J Clin Invest"},{"key":"2024110501464625700_CIT0054","doi-asserted-by":"crossref","first-page":"e133093","DOI":"10.1172\/jci.insight.133093","article-title":"IL-4 induces M2 macrophages to produce sustained analgesia via opioids","volume":"5","author":"Celik","year":"2020","journal-title":"JCI Insight"},{"key":"2024110501464625700_CIT0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.neuron.2021.11.020","article-title":"Macrophages transfer mitochondria to sensory neurons to resolve inflammatory pain","volume":"110","author":"Van der Vlist","year":"2022","journal-title":"Neuron"}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/76\/8\/983\/60416552\/rgae057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/76\/8\/983\/60416552\/rgae057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T01:47:26Z","timestamp":1730771246000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/76\/8\/983\/7669201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,1]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8,1]]},"published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jpp\/rgae057","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,8]]},"published":{"date-parts":[[2024,8,1]]}}}